{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:08:53Z","timestamp":1794557333106,"version":"4.9.1"},"reference-count":153,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.imbio.2011.07.022","type":"journal-article","created":{"date-parts":[[2011,7,28]],"date-time":"2011-07-28T15:00:07Z","timestamp":1311865207000},"page":"235-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome?"],"prefix":"10.1016","volume":"217","author":[{"given":"Sally","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2011.07.022_bib0005","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0002-9440(10)63173-2","article-title":"C5a-induced gene expression in human umbilical vein endothelial cells","volume":"164","author":"Albrecht","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0010","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.molimm.2010.11.015","article-title":"Interactions between Bordetella pertussis and the complement inhibitor factor H","volume":"48","author":"Amdahl","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","article-title":"Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome","volume":"24","author":"Ariceta","year":"2009","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000045586","article-title":"Hemolytic uremic syndrome associated with influenza A virus infection in an adult renal allograft recipient: case report and review of the literature","volume":"84","author":"Asaka","year":"2000","journal-title":"Nephron"},{"key":"10.1016\/j.imbio.2011.07.022_bib0025","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/infdis\/127.6.698","article-title":"Coxsackie virus group B infections and the hemolytic-uremic syndrome","volume":"127","author":"Austin","year":"1973","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imbio.2011.07.022_bib0030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1681\/ASN.V101146","article-title":"Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients","volume":"10","author":"Baid","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1160\/TH10-02-0140","article-title":"Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells","volume":"105","author":"Bauwens","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.imbio.2011.07.022_bib0040","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/INF.0b013e3181db03a7","article-title":"Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children","volume":"29","author":"Bender","year":"2010","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.imbio.2011.07.022_bib0045","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1086\/597471","article-title":"Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura","volume":"48","author":"Benjamin","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.imbio.2011.07.022_bib0050","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/0886022X.2010.486491","article-title":"Triggering of atypical hemolytic uremic syndrome by influenza A (H1N1)","volume":"32","author":"Bento","year":"2010","journal-title":"Ren. Fail."},{"key":"10.1016\/j.imbio.2011.07.022_bib0055","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1002\/1521-4141(200109)31:9<2771::AID-IMMU2771>3.0.CO;2-0","article-title":"Bordetella pertussis binds to human C4b-binding protein (C4BP) at a site similar to that used by the natural ligand C4b","volume":"31","author":"Berggard","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00467-001-0798-6","article-title":"Hemolytic uremic syndrome due to an altered factor H triggered by neonatal pertussis","volume":"17","author":"Berner","year":"2002","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0065","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.ki.5001581","article-title":"A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders","volume":"70","author":"Besbas","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2011.07.022_bib0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ki.2009.472","article-title":"Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome","volume":"77","author":"Bienaime","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2011.07.022_bib0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000185598","article-title":"Hemorrhagic colitis with Streptococcus pyogenes preceding hemolytic uremic syndrome during early pregnancy","volume":"52","author":"Bollaert","year":"1989","journal-title":"Nephron"},{"key":"10.1016\/j.imbio.2011.07.022_bib0080","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1128\/JVI.02444-09","article-title":"Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA\/2 mouse influenza model","volume":"84","author":"Boon","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1542\/peds.110.2.371","article-title":"Invasive pneumococcal disease and hemolytic uremic syndrome","volume":"110","author":"Brandt","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.imbio.2011.07.022_bib0090","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.RES.0000216071.87981.16","article-title":"Differential regulation of endothelial cell activation by complement and interleukin 1alpha","volume":"98","author":"Brunn","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.imbio.2011.07.022_bib0095","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1542\/peds.101.4.699","article-title":"Hemolytic uremic syndrome associated with invasive Streptococcus pneumoniae infection","volume":"101","author":"Cabrera","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.imbio.2011.07.022_bib0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00467-010-1649-0","article-title":"Hemolytic uremic syndrome triggered with a new pandemic virus: influenza A (H1N1)","volume":"26","author":"Caltik","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(73)92645-7","article-title":"Letter: plasma-C3 in haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura","volume":"2","author":"Cameron","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2011.07.022_bib0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1681\/ASN.V122297","article-title":"The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20","volume":"12","author":"Caprioli","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0115","first-page":"342","article-title":"Molecular basis of familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"14","author":"Caprioli","year":"2003","journal-title":"Saudi J. Kidney Dis. Transplant."},{"key":"10.1016\/j.imbio.2011.07.022_bib0120","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.07.022_bib0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1053\/j.ajkd.2008.06.027","article-title":"Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient","volume":"53","author":"Chan","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.imbio.2011.07.022_bib0130","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1053\/ajkd.2001.22099","article-title":"Hemolytic uremic syndrome in an adolescent with Fusobacterium necrophorum bacteremia","volume":"37","author":"Chand","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.imbio.2011.07.022_bib0135","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00467-010-1449-6","article-title":"Hemolytic uremic syndrome caused by Bordetella pertussis infection","volume":"25","author":"Chaturvedi","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pedneo.2011.02.002","article-title":"Nonenteropathic hemolytic uremic syndrome: the experience of a medical center","volume":"52","author":"Chen","year":"2011","journal-title":"Pediatr. Neonatol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00467-003-1382-z","article-title":"Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia","volume":"19","author":"Cochran","year":"2004","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0150","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.ajkd.2004.02.010","article-title":"Non-enteropathic hemolytic uremic syndrome: causes and short-term course","volume":"43","author":"Constantinescu","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.imbio.2011.07.022_bib0155","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s00467-007-0518-y","article-title":"Streptococcus pneumoniae-associated hemolytic uremic syndrome","volume":"11","author":"Copelovitch","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0160","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1053\/j.ajkd.2008.02.359","article-title":"Inherited deficiency of membrane cofactor protein expression and varying manifestations of recurrent atypical hemolytic uremic syndrome in a sibling pair","volume":"52","author":"Couzi","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.imbio.2011.07.022_bib0165","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1537-2995.2000.40070801.x","article-title":"RBC T activation and hemolysis: implications for pediatric transfusion management","volume":"40","author":"Crookston","year":"2000","journal-title":"Transfusion"},{"key":"10.1016\/j.imbio.2011.07.022_bib0170","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1600-6143.2009.02647.x","article-title":"Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP","volume":"9","author":"Cruzado","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.imbio.2011.07.022_bib0175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2010050451","article-title":"The development of atypical hemolytic uremic syndrome depends on complement C5","volume":"22","author":"de Jorge","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0180","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/clinchem\/48.5.781","article-title":"Hemolytic uremic syndrome attributable to Streptococcus pneumoniae infection: a novel cause for secondary protein N-glycan abnormalities","volume":"48","author":"de Loos","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.imbio.2011.07.022_bib0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mib.2008.11.006","article-title":"The effector repertoire of enteropathogenic E. coli: ganging up on the host cell","volume":"12","author":"Dean","year":"2009","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0190","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2011.07.022_bib0195","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jmg.2008.064766","article-title":"The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome","volume":"46","author":"Dragon-Durey","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.imbio.2011.07.022_bib0200","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","article-title":"Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases","volume":"15","author":"Dragon-Durey","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0205","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1681\/ASN.2004050380","article-title":"Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome","volume":"16","author":"Dragon-Durey","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0210","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.imbio.2011.07.022_bib0215","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1093\/clinids\/18.Supplement_4.S253","article-title":"Virulence factors in anaerobes","volume":"18","author":"Duerden","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.imbio.2011.07.022_bib0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.V45.1.11.11","article-title":"Role of sialic acid in erythrocyte survival","volume":"45","author":"Durocher","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.07.022_bib0225","first-page":"219","article-title":"Hemolytic-uremic syndrome in pneumococcal meningitis and infection. Importance of T-transformation","volume":"141","author":"Eber","year":"1993","journal-title":"Monatsschr. Kinderheilkd."},{"key":"10.1016\/j.imbio.2011.07.022_bib0230","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2011.07.022_bib0235","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.molimm.2005.11.008","article-title":"Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree","volume":"43","author":"Esparza-Gordillo","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0240","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1073\/pnas.75.4.1971","article-title":"Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway","volume":"75","author":"Fearon","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2011.07.022_bib0245","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.semnephrol.2008.08.007","article-title":"Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient","volume":"28","author":"Fine","year":"2008","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0250","doi-asserted-by":"crossref","first-page":"19009","DOI":"10.1074\/jbc.M602055200","article-title":"C5b\u20139-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1","volume":"281","author":"Fosbrink","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2011.07.022_bib0255","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1106483","article-title":"Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 Outbreak in Germany \u2013 preliminary report","author":"Frank","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2011.07.022_bib0260","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.imbio.2011.07.022_bib0265","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome","volume":"112","author":"Fremeaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.07.022_bib0270","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1681\/ASN.2005101051","article-title":"Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome","volume":"17","author":"Fremeaux-Bacchi","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0275","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/glycob\/cwj015","article-title":"Murine glycosyltransferases responsible for the expression of globo-series glycolipids: cDNA structures, mRNA expression, and distribution of their products","volume":"15","author":"Fujii","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.imbio.2011.07.022_bib0280","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.imbio.2011.07.022_bib0285","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/344778","article-title":"Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy","volume":"35","author":"Gervasoni","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.imbio.2011.07.022_bib0290","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1056\/NEJM196509302731407","article-title":"Isolation of Coxsackie virus group A, type 4, from a patient with hemolytic-uremic syndrome","volume":"273","author":"Glasgow","year":"1965","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2011.07.022_bib0295","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2011.07.022_bib0300","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00467-010-1687-7","article-title":"Hemolytic uremic syndrome associated with novel influenza A H1N1 infection","volume":"26","author":"Golubovic","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0305","doi-asserted-by":"crossref","first-page":"563","DOI":"10.5414\/CNP71563","article-title":"Hemolytic uremic syndrome as a primary manifestation of acute Human Immunodeficiency Virus infection","volume":"71","author":"Gomes","year":"2009","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0310","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2141.2011.08636.x","article-title":"Human Immunodeficiency Virus associated thrombotic thrombocytopenic purpura \u2013 favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy","volume":"153","author":"Hart","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0315","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-2007-970071","article-title":"Renal complications associated with human parvovirus B19 infection in early childhood","volume":"219","author":"Hartel","year":"2007","journal-title":"Klin. Padiatr."},{"key":"10.1016\/j.imbio.2011.07.022_bib0320","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood-2009-02-205641","article-title":"Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation","volume":"114","author":"Heinen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.07.022_bib0325","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.2006091069","article-title":"Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells","volume":"18","author":"Heinen","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0330","first-page":"58","article-title":"Pneumococcal meningitis complicated with hemolytic uremic syndrome: report of two cases","volume":"39","author":"Huang","year":"1998","journal-title":"Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi"},{"key":"10.1016\/j.imbio.2011.07.022_bib0335","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/tropej\/44.5.308","article-title":"Simultaneous multiple viral infections in childhood acute lower respiratory tract infections in southern Taiwan","volume":"44","author":"Huang","year":"1998","journal-title":"J. Trop. Pediatr."},{"key":"10.1016\/j.imbio.2011.07.022_bib0340","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00042560-200107010-00001","article-title":"Apoptotic effects in primary human umbilical vein endothelial cell cultures caused by exposure to virion-associated and cell membrane-associated HIV-1 gp120","volume":"27","author":"Huang","year":"2001","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.imbio.2011.07.022_bib0345","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1523-1755.1998.00015.x","article-title":"Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells","volume":"54","author":"Hughes","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2011.07.022_bib0350","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1053\/j.ajkd.2005.06.010","article-title":"An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome","volume":"46","author":"Izumi","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.imbio.2011.07.022_bib0355","series-title":"Evidence for Complement Dysregulation in Pneumococcal Haemolytic Uraemic Syndrome","author":"Johnson","year":"2009"},{"key":"10.1016\/j.imbio.2011.07.022_bib0360","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"Jozsi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.07.022_bib0365","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood-2007-02-071472","article-title":"Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome","volume":"110","author":"Jozsi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.07.022_bib0370","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(73)92782-7","article-title":"Letter: serum-complement levels in haemolytic-uraemic syndrome","volume":"2","author":"Kaplan","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2011.07.022_bib0375","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s00467-010-1555-5","article-title":"Genetics and complement in atypical HUS","volume":"25","author":"Kavanagh","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0380","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1681\/ASN.2005010103","article-title":"Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome","volume":"16","author":"Kavanagh","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0385","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molimm.2007.05.004","article-title":"Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome","volume":"45","author":"Kavanagh","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0390","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0140-6736(77)92915-4","article-title":"Thomsen-Friedenreich antigen in haemolytic-uraemic syndrome","volume":"2","author":"Klein","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2011.07.022_bib0395","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1056\/NEJM197804272981702","article-title":"Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes","volume":"298","author":"Koster","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2011.07.022_bib0760","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00011-010-0178-4","article-title":"C5a promotes migration, proliferation, and vessel formation in endothelial cells","volume":"59","author":"Kurihara","year":"2010","journal-title":"Inflamm Res."},{"key":"10.1016\/j.imbio.2011.07.022_bib0400","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/ndt\/gfp166","article-title":"Varicella as a trigger of atypical haemolytic uraemic syndrome associated with complement dysfunction: two cases","volume":"24","author":"Kwon","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"26","key":"10.1016\/j.imbio.2011.07.022_bib0405","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Complement blockade in severe Shiga-toxin, \u00c4\u00ecAssociated HUS","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2011.07.022_bib0410","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00467-008-0967-y","article-title":"Acute renal cortical necrosis due to acquired antiprotein S antibodies","volume":"24","author":"Larakeb","year":"2009","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0415","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cell.2007.06.054","article-title":"Autocrine VEGF signaling is required for vascular homeostasis","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2011.07.022_bib0420","series-title":"Safety & Efficacy of Eculizumab in aHUS Patients Resistant to Plasma Therapy: Interim Analysis from a Phase II Trial","author":"Legendre","year":"2010"},{"key":"10.1016\/j.imbio.2011.07.022_bib0425","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1074\/jbc.M900814200","article-title":"Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome","volume":"284","author":"Lehtinen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2011.07.022_bib0430","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00467-008-0872-4","article-title":"Complement and the atypical hemolytic uremic syndrome in children","volume":"23","author":"Loirat","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0435","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3201\/eid1104.040833","article-title":"Childhood hemolytic uremic syndrome, United Kingdom and Ireland","volume":"11","author":"Lynn","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.imbio.2011.07.022_bib0440","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2011.07.022_bib0445","doi-asserted-by":"crossref","first-page":"41611","DOI":"10.1074\/jbc.M407981200","volume":"279","author":"Mason","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imbio.2011.07.022_bib0450","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.bmt.1702003","article-title":"Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children","volume":"24","author":"Matsuda","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.imbio.2011.07.022_bib0455","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1182\/blood-2002-10-3301","article-title":"Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells","volume":"102","author":"Matussek","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.07.022_bib0460","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.4049\/jimmunol.0900879","article-title":"Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function","volume":"183","author":"Megyeri","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0465","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/adc.65.7.716","article-title":"Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: clinical and epidemiological aspects","volume":"65","author":"Milford","year":"1990","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.imbio.2011.07.022_bib0470","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(74)91463-9","article-title":"Letter: serum-complement levels in haemolytic-uraemic syndrome","volume":"2","author":"Monnens","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2011.07.022_bib0475","first-page":"168","article-title":"The complement system in hemolytic-uremic syndrome in childhood","volume":"13","author":"Monnens","year":"1980","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0480","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4 and with mutations in CFH, CFI, CD46, and C3 in patients with atypical haemolytic uraemic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.07.022_bib0485","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1537-2995.1975.15476034552.x","article-title":"Severe hemolytic anemia in an adult associated with anti-T","volume":"15","author":"Moores","year":"1975","journal-title":"Transfusion"},{"key":"10.1016\/j.imbio.2011.07.022_bib0490","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant c3a formation that triggers microvascular thrombosis","volume":"187","author":"Morigi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0495","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1182\/blood.V86.12.4553.bloodjournal86124553","article-title":"Verotoxin-1 promotes leukocyte adhesion to cultured endothelial cells under physiologic flow conditions","volume":"86","author":"Morigi","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.07.022_bib0500","series-title":"Safety & Efficacy of Eculizumab in aHUS Patients on Chronic Plasma Therapy: Interim Analysis of a Phase II Trial","author":"Muus","year":"2010"},{"key":"10.1016\/j.imbio.2011.07.022_bib0505","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1385\/IR:24:2:191","article-title":"Mechanisms of signal transduction activated by sublytic assembly of terminal complement complexes on nucleated cells","volume":"24","author":"Niculescu","year":"2001","journal-title":"Immunol. Res."},{"key":"10.1016\/j.imbio.2011.07.022_bib0510","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/S0140-6736(03)14742-3","article-title":"Familial haemolytic uraemic syndrome and an MCP mutation","volume":"362","author":"Noris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2011.07.022_bib0515","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0520","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2011.07.022_bib0525","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/15513818309025872","article-title":"Hemolytic-uremic syndrome and T-cryptantigen exposure by neuraminidase-producing pneumococci: an emerging problem?","volume":"1","author":"Novak","year":"1983","journal-title":"Pediatr. Pathol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0530","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/bj2440287","article-title":"The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis","volume":"244","author":"Obrig","year":"1987","journal-title":"Biochem. J."},{"key":"10.1016\/j.imbio.2011.07.022_bib0535","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1348-0421.2011.00309.x","article-title":"Serum concentrations of complement anaphylatoxins and proinflammatory mediators in patients with 2009 H1N1 influenza","volume":"55","author":"Ohta","year":"2011","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0540","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0545","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2249.2008.03826.x","article-title":"Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice","volume":"155","author":"Paixao-Cavalcante","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0550","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.4049\/jimmunol.164.9.4742","article-title":"Molecular mechanisms of target recognition in an innate immune system: interactions among factor H, C3b, and target in the alternative pathway of human complement 2","volume":"164","author":"Pangburn","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0555","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1084\/jem.146.1.257","article-title":"Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution","volume":"146","author":"Pangburn","year":"1977","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2011.07.022_bib0560","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10096-006-0171-6","article-title":"Hemolytic uremic syndrome in an infant following Bordetella pertussis infection","volume":"25","author":"Pela","year":"2006","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.imbio.2011.07.022_bib0565","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome","volume":"68","author":"Perez-Caballero","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.imbio.2011.07.022_bib0570","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1038\/ki.2008.612","article-title":"Verotoxin biology: molecular events in vascular endothelial injury","author":"Petruzziello","year":"2009","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.imbio.2011.07.022_bib0575","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1016\/j.molimm.2008.02.008","article-title":"Molecular characterization of Complement Factor I deficiency in two Spanish families","volume":"45","author":"Ponce-Castro","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0580","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00467-010-1603-1","article-title":"Pandemic influenza A (H1N1) 2009-associated hemolytic uremic syndrome","volume":"26","author":"Printza","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0585","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1365-2141.2001.02301.x","article-title":"T activation","volume":"112","author":"Ramasethu","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0590","doi-asserted-by":"crossref","first-page":"12966","DOI":"10.1073\/pnas.2135497100","article-title":"Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome","volume":"100","author":"Richards","year":"2003","journal-title":"Proc. Natl. Acta. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2011.07.022_bib0595","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000187063","article-title":"Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome","volume":"62","author":"Robson","year":"1992","journal-title":"Nephron"},{"key":"10.1016\/j.imbio.2011.07.022_bib0600","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MBC.0b013e328325546f","article-title":"HIV, thrombotic thrombocytopaenic purpura and rituximab in a violent noncompliant patient","volume":"20","author":"Ross","year":"2009","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.imbio.2011.07.022_bib0605","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2009-01-197640","article-title":"Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome","volume":"114","author":"Roumenina","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.07.022_bib0610","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1046\/j.1523-1755.2001.060003831.x","article-title":"Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura","volume":"60","author":"Ruggenenti","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2011.07.022_bib0615","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1160\/TH04-07-0450","article-title":"Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies","volume":"93","author":"Ruiz-Torres","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.imbio.2011.07.022_bib0765","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/ATVBAHA.110.205559","article-title":"The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury","volume":"30","author":"Sakuma","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0620","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0022-3468(81)80844-5","article-title":"Pediatric surgical patients with severe anaerobic infection: report of 16 T-antigen positive cases and possible hazards of blood transfusion","volume":"16","author":"Seges","year":"1981","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.imbio.2011.07.022_bib0625","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome","volume":"18","author":"Sellier-Leclerc","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0630","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1093\/ndt\/14.10.2472","article-title":"Haemolytic-uraemic syndrome following human parvovirus infection in a previously fit adult","volume":"14","author":"Seward","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.imbio.2011.07.022_bib0635","first-page":"49","article-title":"Hemolytic uremic syndrome following chicken pox","volume":"14","author":"Sharman","year":"1980","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0640","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00467-003-1191-4","article-title":"Hemolytic uremic syndrome associated with group A beta-hemolytic streptococcus","volume":"18","author":"Shepherd","year":"2003","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0645","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1681\/ASN.2010030295","article-title":"Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling","volume":"21","author":"Sison","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0650","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1167\/iovs.10-5322","article-title":"Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells","volume":"51","author":"Skeie","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.imbio.2011.07.022_bib0655","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2215\/CJN.0200608","article-title":"Iron-related proteins: candidate urine biomarkers in childhood HIV-associated renal diseases","volume":"4","author":"Soler-Garcia","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"20","key":"10.1016\/j.imbio.2011.07.022_bib0660","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","article-title":"Complement activation on platelet\u2013leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome","volume":"117","author":"Stahl","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2011.07.022_bib0665","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00385634","article-title":"Fusobacterium necrophorum infections: virulence factors, pathogenic mechanism and control measures","volume":"20","author":"Tan","year":"1996","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.imbio.2011.07.022_bib0670","first-page":"1073","article-title":"Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome","volume":"365","author":"Tarr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.imbio.2011.07.022_bib0675","first-page":"85","volume":"52","author":"Thomsen","year":"1927","journal-title":"Z. ImmunForsch"},{"key":"10.1016\/j.imbio.2011.07.022_bib0680","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome","volume":"4","author":"Thurman","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0685","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00467-010-1636-5","article-title":"Atypical hemolytic uremic syndrome associated with H1N1 influenza A virus infection","volume":"26","author":"Trachtman","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0690","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1681\/ASN.V8121877","article-title":"Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms","volume":"8","author":"Van Setten","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0695","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","article-title":"Atypical haemolytic uraemic syndrome associated with a hybrid complement gene","volume":"3","author":"Venables","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.imbio.2011.07.022_bib0700","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1523-1755.1998.00824.x","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","volume":"53","author":"Warwicker","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2011.07.022_bib0705","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1086\/381124","article-title":"Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections","volume":"189","author":"Watanabe","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imbio.2011.07.022_bib0710","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000046102","article-title":"Hemolytic uremic syndrome associated with influenza A virus infection","volume":"89","author":"Watanabe","year":"2001","journal-title":"Nephron"},{"key":"10.1016\/j.imbio.2011.07.022_bib0715","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpeds.2007.03.055","article-title":"Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience","volume":"151","author":"Waters","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.imbio.2011.07.022_bib0720","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/507111","article-title":"Dengue fever-induced hemolytic uremic syndrome","volume":"43","author":"Wiersinga","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.imbio.2011.07.022_bib0725","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0022-3476(89)80748-6","article-title":"Transfusion of infants with activation of erythrocyte T antigen","volume":"115","author":"Williams","year":"1989","journal-title":"J. Pediatr."},{"key":"10.1016\/j.imbio.2011.07.022_bib0730","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00467-004-1536-7","article-title":"Atypical hemolytic uremic syndrome associated with Group A beta hemolytic streptococcus","volume":"19","author":"Yildiz","year":"2004","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0735","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.bbrc.2007.05.058","article-title":"Suppression of complement regulatory protein C1 inhibitor in vascular endothelial activation by inhibiting vascular cell adhesion molecule-1 action","volume":"358","author":"Zhang","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.imbio.2011.07.022_bib0740","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0745","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1016\/j.molimm.2007.06.149","article-title":"Complement evasion of pathogens: common strategies are shared by diverse organisms","volume":"44","author":"Zipfel","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2011.07.022_bib0750","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1523-1755.2002.00503.x","article-title":"Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1","volume":"62","author":"Zoja","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.imbio.2011.07.022_bib0755","first-page":"229","article-title":"Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabbits given verotoxin-1","volume":"120","author":"Zoja","year":"1992","journal-title":"J. Lab. Clin. Med."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298511001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298511001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:31:22Z","timestamp":1759249882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298511001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":153,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0171298511001628"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2011.07.022","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome?","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2011.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}